Tags

Type your tag names separated by a space and hit enter

Neurodegenerative diseases and Withania somnifera (L.): An update.
J Ethnopharmacol. 2020 Jun 28; 256:112769.JE

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Withania somnifera (L.) Dunal also known as 'Ashwaghanda' in Sanskrit and as 'Indian Winter Cherry' in english. is an important medicinal herb in India. It is widely used in Indian systems of medicine as an adaptogen, nerve tonic, anti-stress, memory enhancer and against cognitive deficits, insomnia, anxiety, infectious diseases, infertility, rheumatoid arthritis and gout over thousands of years. Its formulations are mainly used in Unani and Ayurvedic system of medicine. It is a remarkable centuries old herbal Rasayana used to treat neuronal ailments and is known as ''Sattvic Kapha Rasayana.

AIM OF THE STUDY

To review neuroprotective properties of Withania somnifera (L.)extract as well as its active constituents in neurodegenerative diseases and other neurological ailments.

MATERIALS AND METHODS

The sources of information used in present article include Indian system of Medicine reports on the use of natural products, Medicinal books, research articles and scientific databases like PubMed, Google Scholar, Web of Science, Science-Direct, SciFinder, ACS Publications and Wiley Online Library.

RESULTS

Research reports based largely on preclinical studies as well as few clinical trials have highlighted the neuroprotective role of Ashwagandha against many neurodegenerative diseases including Alzheimer's, Huntington's and Parkinson's disease. The protective effects of Ashwagandha were accomplished by restoring mitochondrial and endothelial function, mitigation of apoptosis, inflammation and oxidative stress mechanisms.

CONCLUSION

In this review, we recapitulated neuroprotective properties of Ashwagandha extracts and/or its major constituents and discussed their mechanisms of action and potential therapeutic applications. The pre-clinical as well as clinical studies suggest the use of Withania somnifera (L.) against neurodegenerative disease. However, extensive studies are warranted to validate the use of extract or its single constituents for its clinical use.

Authors+Show Affiliations

Neuropharmacology Laboratory, Indian Institute of Integrative Medicine-CSIR, Sanat Nagar, Srinagar, 190005, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.Neuropharmacology Laboratory, Indian Institute of Integrative Medicine-CSIR, Sanat Nagar, Srinagar, 190005, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: mahmad@iiim.ac.in.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32240781

Citation

Dar, Nawab John, and MuzamilAhmad. "Neurodegenerative Diseases and Withania Somnifera (L.): an Update." Journal of Ethnopharmacology, vol. 256, 2020, p. 112769.
Dar NJ, MuzamilAhmad . Neurodegenerative diseases and Withania somnifera (L.): An update. J Ethnopharmacol. 2020;256:112769.
Dar, N. J., & MuzamilAhmad, . (2020). Neurodegenerative diseases and Withania somnifera (L.): An update. Journal of Ethnopharmacology, 256, 112769. https://doi.org/10.1016/j.jep.2020.112769
Dar NJ, MuzamilAhmad . Neurodegenerative Diseases and Withania Somnifera (L.): an Update. J Ethnopharmacol. 2020 Jun 28;256:112769. PubMed PMID: 32240781.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neurodegenerative diseases and Withania somnifera (L.): An update. AU - Dar,Nawab John, AU - MuzamilAhmad,, Y1 - 2020/03/30/ PY - 2019/09/30/received PY - 2020/01/28/revised PY - 2020/03/13/accepted PY - 2020/4/3/pubmed PY - 2021/1/28/medline PY - 2020/4/3/entrez KW - Alzheimer's disease KW - Anti-inflammatory KW - Anti-stress KW - Huntington's KW - Nerve tonic KW - Neuroprotection KW - Parkinson's disease KW - Stroke KW - Withania somnifera KW - Withanolide-A KW - Withanone SP - 112769 EP - 112769 JF - Journal of ethnopharmacology JO - J Ethnopharmacol VL - 256 N2 - ETHNOPHARMACOLOGICAL RELEVANCE: Withania somnifera (L.) Dunal also known as 'Ashwaghanda' in Sanskrit and as 'Indian Winter Cherry' in english. is an important medicinal herb in India. It is widely used in Indian systems of medicine as an adaptogen, nerve tonic, anti-stress, memory enhancer and against cognitive deficits, insomnia, anxiety, infectious diseases, infertility, rheumatoid arthritis and gout over thousands of years. Its formulations are mainly used in Unani and Ayurvedic system of medicine. It is a remarkable centuries old herbal Rasayana used to treat neuronal ailments and is known as ''Sattvic Kapha Rasayana. AIM OF THE STUDY: To review neuroprotective properties of Withania somnifera (L.)extract as well as its active constituents in neurodegenerative diseases and other neurological ailments. MATERIALS AND METHODS: The sources of information used in present article include Indian system of Medicine reports on the use of natural products, Medicinal books, research articles and scientific databases like PubMed, Google Scholar, Web of Science, Science-Direct, SciFinder, ACS Publications and Wiley Online Library. RESULTS: Research reports based largely on preclinical studies as well as few clinical trials have highlighted the neuroprotective role of Ashwagandha against many neurodegenerative diseases including Alzheimer's, Huntington's and Parkinson's disease. The protective effects of Ashwagandha were accomplished by restoring mitochondrial and endothelial function, mitigation of apoptosis, inflammation and oxidative stress mechanisms. CONCLUSION: In this review, we recapitulated neuroprotective properties of Ashwagandha extracts and/or its major constituents and discussed their mechanisms of action and potential therapeutic applications. The pre-clinical as well as clinical studies suggest the use of Withania somnifera (L.) against neurodegenerative disease. However, extensive studies are warranted to validate the use of extract or its single constituents for its clinical use. SN - 1872-7573 UR - https://www.unboundmedicine.com/medline/citation/32240781/Neurodegenerative_diseases_and_Withania_somnifera__L__:_An_update_ DB - PRIME DP - Unbound Medicine ER -